The enemy within: keeping self-reactive T cells at bay in the periphery (original) (raw)

• Arstila, T. P. et al. A direct estimate of the human αβT cell receptor diversity. Science 286, 958–961 (1999).
  CAS PubMed Google Scholar
• Mason, D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19, 395–404 (1998).
  CAS PubMed Google Scholar
• Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nature Immunol. 2, 1032–1039 (2001).
  CAS Google Scholar
• Lohmann, T., Leslie, R. D. & Londei, M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9, 385–389 (1996).
  CAS PubMed Google Scholar
• Semana, G., Gausling, R., Jackson, R. A. & Hafler, D. A. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J. Autoimmun. 12, 259–267 (1999).
  CAS PubMed Google Scholar
• Bouneaud, C., Kourilsky, P. & Bousso, P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13, 829–840 (2000).
  CAS PubMed Google Scholar
• Alferink, J. et al. Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking. Science 282, 1338–1341 (1998).
  CAS PubMed Google Scholar
• Zinkernagel, R. M. Immunology taught by viruses. Science 271, 173–178 (1996).
  Article CAS PubMed Google Scholar
• Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R. & Heath, W. R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188, 409–414 (1998).
  CAS PubMed PubMed Central Google Scholar
• Hoglund, P. et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med.. 189, 331–339 (1999).Pancreatic, but not renal, antigen presentation is compromised in juvenile mice, probably explaining the delay in onset of disease in diabetes-prone mouse strains.
  CAS PubMed PubMed Central Google Scholar
• Andre, I. et al. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl Acad. Sci. USA 93, 2260–2263 (1996).
  CAS PubMed PubMed Central Google Scholar
• Jenkins, M. K. & Schwartz, R. H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302–319 (1987).
  CAS PubMed Google Scholar
• Lane, P., Haller, C. & McConnell, F. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4–Ig protects Vβ8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur. J. Immunol. 26, 858–862 (1996).
  CAS PubMed Google Scholar
• Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459–465 (1995).
  CAS PubMed Google Scholar
• Walunas, T. L., Bakker, C. Y. & Bluestone, J. A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541–2550 (1996).
  CAS PubMed Google Scholar
• Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411–417 (1997).
  CAS PubMed Google Scholar
• Walunas, T. L. & Bluestone, J. A. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160, 3855–3860 (1998).
  CAS PubMed Google Scholar
• Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541–547 (1995).
  CAS PubMed Google Scholar
• Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985–988 (1995).
  CAS PubMed Google Scholar
• Lechner, O. et al. Fingerprints of anergic T cells. Curr. Biol. 11, 587–595 (2001).
  CAS PubMed Google Scholar
• Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151 (1999).Mice on a C57/BL6 background that lack PD-1 exhibit glomerulonephritis and arthritis that is exacerbated if the Fas pathway is also defective. Lymphocytic infiltration of multiple organs is observed in 2C TCR transgenic mice that lack PD–1.
  CAS PubMed Google Scholar
• Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319–322 (2001).
  CAS PubMed Google Scholar
• Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
  CAS PubMed PubMed Central Google Scholar
• Latchman, Y. et al. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nature Immunol. 2, 261–268 (2001).
  CAS Google Scholar
• Chambers, C. A. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 22, 217–223 (2001).
  CAS PubMed Google Scholar
• Pape, K. A., Merica, R., Mondino, A., Khoruts, A. & Jenkins, M. K. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719–4729 (1998).CD4+ OVA-specific TCR transgenic T cells persist in vivo for several months following tolerogenic administration of soluble OVA peptide.
  CAS PubMed Google Scholar
• Young, D. A. et al. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand- specific TH2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 164, 3563–3572 (2000).
  CAS PubMed Google Scholar
• Bradley, L. M. et al. Islet-specific TH1, but not TH2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162, 2511–2520 (1999).
  CAS PubMed Google Scholar
• Pakala, S. V., Kurrer, M. O. & Katz, J. D. T helper 2 (TH2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186, 299–306 (1997).
  CAS PubMed PubMed Central Google Scholar
• Charles, P. C., Weber, K. S., Cipriani, B. & Brosnan, C. F. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a TH1/TH2 bias. J. Neuroimmunol. 100, 64–73 (1999).
  CAS PubMed Google Scholar
• Chensue, S. W. et al. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193, 573–584 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327–339 (1994).
  CAS PubMed Google Scholar
• Walker, L. S. et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190, 1115–1122 (1999).
  CAS PubMed PubMed Central Google Scholar
• Ansel, K. M., McHeyzer-Williams, L. J., Ngo, V. N., McHeyzer-Williams, M. G. & Cyster, J. G. _in vivo_-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190, 1123–1134 (1999).
  CAS PubMed PubMed Central Google Scholar
• Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471–481 (2000).
  CAS PubMed Google Scholar
• Ishikawa, S. et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193, 1393–1402 (2001).
  CAS PubMed PubMed Central Google Scholar
• Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).First direct evidence for a non-redundant role of the Fas pathway in maintaining self-tolerance.
  CAS PubMed Google Scholar
• Sobel, E. S., Kakkanaiah, V. N., Cohen, P. L. & Eisenberg, R. A. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int. Immunol. 5, 1275–1278 (1993).
  CAS PubMed Google Scholar
• Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169–1178 (1993).
  CAS PubMed Google Scholar
• Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).
  CAS PubMed Google Scholar
• Suzuki, A. et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523–534 (2001).
  CAS PubMed Google Scholar
• Chen, W. et al. Requirement for transforming growth factor β1 in controlling T cell apoptosis. J. Exp. Med. 194, 439–454 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lenardo, M. J. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858–861 (1991).
  CAS PubMed Google Scholar
• Van Parijs, L. et al. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158, 3738–3745 (1997).
  CAS PubMed Google Scholar
• Van Parijs, L. et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11, 281–288 (1999).
  CAS PubMed Google Scholar
• Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J. & Abbas, A. K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615–623 (1998).
  CAS PubMed Google Scholar
• Sadlack, B. et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25, 3053–3059 (1995).
  CAS PubMed Google Scholar
• Willerford, D. M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
  CAS PubMed Google Scholar
• Malek, T. R., Porter, B. O., Codias, E. K., Scibelli, P. & Yu, A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164, 2905–2914 (2000).
  CAS PubMed Google Scholar
• Singer, G. G. & Abbas, A. K. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365–371 (1994).In vivo peptide administration induces thymic deletion even in the absence of Fas signalling, but peripheral T-cell deletion is impaired.
  CAS PubMed Google Scholar
• Mogil, R. J. et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7, 1451–1458 (1995).
  CAS PubMed Google Scholar
• Ettinger, R. et al. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J. Immunol. 154, 4302–4308 (1995).
  CAS PubMed Google Scholar
• Hildeman, D. A. et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735–744 (1999).
  CAS PubMed Google Scholar
• Van Parijs, L., Peterson, D. A. & Abbas, A. K. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8, 265–274 (1998).
  CAS PubMed Google Scholar
• Janeway, C. A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11–16 (1992).
  CAS PubMed Google Scholar
• Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).Cloning and characterization of a human homologue of the Drosophila Toll protein that can activate the NF-κB pathway.
  CAS PubMed Google Scholar
• Aderem, A. & Ulevitch, R. J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782–787 (2000).
  CAS PubMed Google Scholar
• Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
  CAS PubMed Google Scholar
• Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
  CAS PubMed Google Scholar
• Basu, S., Binder, R. J., Suto, R., Anderson, K. M. & Srivastava, P. K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12, 1539–1546 (2000).
  CAS PubMed Google Scholar
• Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923–930 (1996).First demonstration of how tissue-associated antigens, which are not accessible to recirculating T cells, can be presented by bone-marrow-derived APCs to CD8 T cells in the context of MHC class I.
  CAS PubMed Google Scholar
• Adler, A. J. et al. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med. 187, 1555–1564 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kurts, C., Cannarile, M., Klebba, I. & Brocker, T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166, 1439–1442 (2001).
  CAS PubMed Google Scholar
• Hirao, M. et al. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 60, 2209–2217 (2000).
  CAS PubMed Google Scholar
• Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249–1255 (1999).
  CAS PubMed Google Scholar
• Sauter, B. et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423–434 (2000).
  CAS PubMed PubMed Central Google Scholar
• Huang, F. P. et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435–444 (2000).
  CAS PubMed PubMed Central Google Scholar
• Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163–2173 (1998).
  CAS PubMed PubMed Central Google Scholar
• Thery, C. et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein HSC 73. J. Cell Biol. 147, 599–610 (1999).
  CAS PubMed PubMed Central Google Scholar
• Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233–238 (2001).
  CAS PubMed PubMed Central Google Scholar
• Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387–396 (1996).Removal of the thymus at day 3 after birth eliminates the regulatory CD4+CD25+ cell subset from the periphery and is associated with onset of autoimmunity that can be prevented by inoculation with CD25+ cells from normal mice.
  CAS PubMed Google Scholar
• Thornton, A. M. & Shevach, E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183–190 (2000).
  CAS PubMed Google Scholar
• Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kuniyasu, Y. et al. Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12, 1145–1155 (2000).
  CAS PubMed Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  CAS PubMed Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  CAS PubMed PubMed Central Google Scholar
• Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. & Sharpe, A. H. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145–155 (2001).
  CAS PubMed Google Scholar
• Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
  CAS PubMed Google Scholar
• Wakkach, A., Cottrez, F. & Groux, H. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. 167, 3107–3113 (2001).
  CAS PubMed Google Scholar
• Groux, H., Bigler, M., de Vries, J. E. & Roncarolo, M. G. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 160, 3188–3193 (1998).
  CAS PubMed Google Scholar
• Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. & Enk, A. H. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213–1222 (2000).
  CAS PubMed PubMed Central Google Scholar
• Powrie, F., Carlino, J., Leach, M. W., Mauze, S. & Coffman, R. L. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J. Exp. Med. 183, 2669–2674 (1996).Colitis induced by CD45RB hi cells in SCID mice is prevented by co-transfer of CD45RB low cells: IL-10 and TGF-β are required for this effect.
  CAS PubMed Google Scholar
• Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
  CAS PubMed PubMed Central Google Scholar
• Quinn, A. et al. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct Vβ genes. J. Immunol. 166, 2982–2991 (2001).
  CAS PubMed Google Scholar
• Miller, S. D. et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature Med. 3, 1133–1136 (1997).
  CAS PubMed Google Scholar
• Zhao, Z. S., Granucci, F., Yeh, L., Schaffer, P. A. & Cantor, H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279, 1344–1347 (1998).
  CAS PubMed Google Scholar
• Bachmaier, K. et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283, 1335–1339 (1999).
  CAS PubMed Google Scholar
• Hemmer, B. et al. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160, 3631–3636 (1998).
  CAS PubMed Google Scholar
• Hiemstra, H. S. et al. Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases. Eur. J. Immunol. 29, 2385–2391 (1999).
  CAS PubMed Google Scholar
• Steere, A. C., Gross, D., Meyer, A. L. & Huber, B. T. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J. Autoimmun. 16, 263–268 (2001).
  CAS PubMed Google Scholar
• Gautam, A. M., Liblau, R., Chelvanayagam, G., Steinman, L. & Boston, T. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis. J. Immunol. 161, 60–64 (1998).
  CAS PubMed Google Scholar
• Panoutsakopoulou, V. et al. Analysis of the relationship between viral infection and autoimmune disease. Immunity 15, 137–147 (2001).
  CAS PubMed Google Scholar
• Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025–4031 (1991).
  CAS PubMed PubMed Central Google Scholar
• Horwitz, M. S. et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Med. 4, 781–785 (1998).
  CAS PubMed Google Scholar
• Ehl, S. et al. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 187, 763–774 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shi, F. D. et al. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nature Immunol. 1, 245–251 (2000).
  CAS Google Scholar
• Gombert, J. M. et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998 (1996).
  CAS PubMed Google Scholar
• Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).
  CAS PubMed PubMed Central Google Scholar
• Wang, B., Geng, Y. B. & Wang, C. R. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320 (2001).
  PubMed PubMed Central Google Scholar
• Jordan, M. S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301–306 (2001).
  CAS Google Scholar
• Bensinger, S. J., Bandeira, A., Jordan, M. S., Caton, A. J. & Laufer, T. M. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells. J. Exp. Med. 194, 427–438 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kumanogoh, A. et al. Increased T cell autoreactivity in the absence of CD40–CD40 ligand interactions: a role of CD40 in regulatory T cell development. J. Immunol. 166, 353–360 (2001).
  CAS PubMed Google Scholar